Cambridge Investment Research Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.33M | Buy |
76,772
+11,409
| +17% | +$1.1M | 0.02% | 828 |
|
|
2026
Q1 | $6.77M | Sell |
65,363
-24
| -0% | -$2.72K | 0.02% | 799 |
|
|
2025
Q4 | $6.59M | Sell |
65,387
-1,746
| -3% | -$190K | 0.02% | 776 |
|
|
2025
Q3 | $8.28M | Buy |
67,133
+10,164
| +18% | +$1.26M | 0.02% | 652 |
|
|
2025
Q2 | $6.84M | Sell |
56,969
-28,797
| -34% | -$3.84M | 0.02% | 703 |
|
|
2025
Q1 | $12.6M | Buy |
85,766
+44,246
| +107% | +$6.76M | 0.04% | 421 |
|
|
2024
Q4 | $6.74M | Sell |
41,520
-6,996
| -14% | -$1.14M | 0.02% | 645 |
|
|
2024
Q3 | $7.9M | Buy |
48,516
+6,041
| +14% | +$895K | 0.03% | 587 |
|
|
2024
Q2 | $5.8M | Sell |
42,475
-6,611
| -13% | -$918K | 0.02% | 684 |
|
|
2024
Q1 | $7.52M | Buy |
49,086
+984
| +2% | +$147K | 0.03% | 563 |
|
|
2023
Q4 | $6.86M | Buy |
48,102
+498
| +1% | +$66.4K | 0.03% | 563 |
|
|
2023
Q3 | $6.24M | Sell |
47,604
-1,918
| -4% | -$291K | 0.03% | 561 |
|
|
2023
Q2 | $7.88M | Buy |
49,522
+3,809
| +8% | +$614K | 0.04% | 465 |
|
|
2023
Q1 | $7.23M | Buy |
45,713
+1,128
| +3% | +$169K | 0.04% | 468 |
|
|
2022
Q4 | $6.26M | Sell |
44,585
-1,688
| -4% | -$240K | 0.03% | 506 |
|
|
2022
Q3 | $5.94M | Buy |
46,273
+8,411
| +22% | +$1.21M | 0.03% | 491 |
|
|
2022
Q2 | $5.34M | Sell |
37,862
-1,312
| -3% | -$187K | 0.03% | 560 |
|
|
2022
Q1 | $5.45M | Buy |
39,174
+142
| +0.4% | +$21.8K | 0.03% | 598 |
|
|
2021
Q4 | $6.81M | Sell |
39,032
-1,514
| -4% | -$252K | 0.03% | 523 |
|
|
2021
Q3 | $6.71M | Buy |
40,546
+6,733
| +20% | +$1.16M | 0.03% | 492 |
|
|
2021
Q2 | $6.08M | Sell |
33,813
-9,611
| -22% | -$1.75M | 0.03% | 535 |
|
|
2021
Q1 | $8.38M | Buy |
43,424
+3,631
| +9% | +$699K | 0.05% | 383 |
|
|
2020
Q4 | $8.04M | Buy |
39,793
+4,054
| +11% | +$839K | 0.05% | 359 |
|
|
2020
Q3 | $7.51M | Sell |
35,739
-1,913
| -5% | -$426K | 0.05% | 342 |
|
|
2020
Q2 | $8.26M | Sell |
37,652
-8,402
| -18% | -$1.68M | 0.06% | 297 |
|
|
2020
Q1 | $7.98M | Buy |
46,054
+16,754
| +57% | +$2.77M | 0.08% | 249 |
|
|
2019
Q4 | $4.5M | Buy |
29,300
+1,770
| +6% | +$265K | 0.03% | 504 |
|
|
2019
Q3 | $4.18M | Buy |
27,530
+124
| +0.5% | +$19.6K | 0.04% | 492 |
|
|
2019
Q2 | $4.2M | Buy |
27,406
+858
| +3% | +$131K | 0.04% | 457 |
|
|
2019
Q1 | $4.26M | Buy |
26,548
+423
| +2% | +$65.6K | 0.04% | 422 |
|
|
2018
Q4 | $4.03M | Sell |
26,125
-581
| -2% | -$90.5K | 0.04% | 396 |
|
|
2018
Q3 | $4.02M | Sell |
26,706
-4,659
| -15% | -$662K | 0.04% | 436 |
|
|
2018
Q2 | $4.24M | Buy |
31,365
+4,304
| +16% | +$531K | 0.04% | 386 |
|
|
2018
Q1 | $3.6M | Sell |
27,061
-1,402
| -5% | -$188K | 0.04% | 413 |
|
|
2017
Q4 | $4.23M | Buy |
28,463
+951
| +3% | +$129K | 0.05% | 349 |
|
|
2017
Q3 | $3.63M | Sell |
27,512
-3,922
| -12% | -$527K | 0.05% | 339 |
|
|
2017
Q2 | $4.19M | Buy |
31,434
+57
| +0.2% | +$7.69K | 0.06% | 301 |
|
|
2017
Q1 | $4.23M | Buy |
31,377
+671
| +2% | +$86.9K | 0.07% | 259 |
|
|
2016
Q4 | $3.69M | Sell |
30,706
-3,609
| -11% | -$426K | 0.07% | 265 |
|
|
2016
Q3 | $4.3M | Buy |
34,315
+1,350
| +4% | +$177K | 0.08% | 241 |
|
|
2016
Q2 | $4.56M | Buy |
32,965
+2,631
| +9% | +$341K | 0.1% | 195 |
|
|
2016
Q1 | $3.82M | Buy |
30,334
+1,325
| +5% | +$168K | 0.09% | 215 |
|
|
2015
Q4 | $3.68M | Sell |
29,009
-2,491
| -8% | -$309K | 0.09% | 226 |
|
|
2015
Q3 | $3.64M | Buy |
31,500
+1,788
| +6% | +$201K | 0.1% | 191 |
|
|
2015
Q2 | $3.09M | Buy |
29,712
+3,229
| +12% | +$348K | 0.09% | 233 |
|
|
2015
Q1 | $2.92M | Buy |
26,483
+1,363
| +5% | +$148K | 0.08% | 240 |
|
|
2014
Q4 | $2.62M | Sell |
25,120
-130
| -0.5% | -$13K | 0.08% | 238 |
|
|
2014
Q3 | $2.42M | Buy |
25,250
+4,026
| +19% | +$364K | 0.07% | 269 |
|
|
2014
Q2 | $1.94M | Buy |
21,224
+2,736
| +15% | +$245K | 0.07% | 281 |
|
|
2014
Q1 | $1.63M | Buy |
18,488
+3,302
| +22% | +$290K | 0.06% | 307 |
|
|
2013
Q4 | $1.41M | Buy |
15,186
+1,686
| +12% | +$152K | 0.06% | 313 |
|
|
2013
Q3 | $1.1M | Buy |
13,500
+2,378
| +21% | +$201K | 0.05% | 336 |
|
|
2013
Q2 | $925K | Buy |
+11,122
| New | +$957K | 0.05% | 339 |
|
Other funds holding CLX
Cambridge Investment Research Advisors's CLX Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Clorox (CLX) stake by 17% in Q2 2026, buying an estimated $1.1M and bringing the position to 76,772 shares worth $7.33M. The position accounts for 0.02% of the portfolio, ranked #828.
Cambridge Investment Research Advisors first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.6M in Q1 2025. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Cambridge Investment Research Advisors held 76,772 shares of Clorox worth $7.33M as of Q2 2026.
- Cambridge Investment Research Advisors bought 11,409 Clorox shares in Q2 2026, an estimated $1.1M.
- Clorox made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #828 holding.
- Cambridge Investment Research Advisors first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
- Cambridge Investment Research Advisors's Clorox position peaked at $12.6M in Q1 2025.
- 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.